Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00135408
Status:
COMPLETED
Last Update Posted:
2016-09-28
First Post:
2005-08-25
Brief Title:
A Study of MDX-010 BMS-734016 Administered With or Without Prophylactic Oral Budesonide
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Malignant Melanoma |
Keywords:
| Name | View |
|---|---|
| Unresectable Stage III or IV Malignant Melanoma | View |